Stocks were indicated to open marginally higher on Monday after solid gains on Friday. Investors are still dealing with mixed news reports, trade policies, politics and the slightly less robust business coverage. Those same investors also should be considering how they want their assets positioned for the rest of 2019 and beyond.
24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to find new ideas for investors and traders alike. Some of these analyst reports cover stocks to buy, while others cover stocks to sell or to avoid.
Additional commentary has been added on most of the daily analyst reports, along with trading history. The consensus analyst price targets and other valuation metrics are from the Refinitiv (Thomson Reuters) sell-side research service.
These were the top analyst upgrades, downgrades and initiations seen on Monday, March 4, 2019.
Alector Inc. (NASDAQ: ALEC) has seen its quiet period end and the ratings appear to be positive. It was started as Overweight at Morgan Stanley and as Overweight at Barclays. It was also started as Buy at Merrill Lynch and as Outperform at Leerink.
Avangrid Inc. (NYSE: AGR) was downgraded to Neutral from Outperform at Macquarie.
Bed Bath & Beyond Inc. (NASDAQ: BBBY) was downgraded to Underweight from Equal Weight at Barclays. After closing down 0.24% at $16.69 on Friday, Monday’s indications were down almost 3% at $16.20.
Bio-Techne Corp. (NASDAQ: TECH) was reiterated as Buy with a $230 price target (versus a $196.81 prior closing price) at Argus. The consensus target price is $202.50.
Dillard’s Inc. (NYSE: DDS) was downgraded to Underweight from Neutral at JPMorgan. The shares last closed at $75.21, in a 52-week range of $55.73 to $98.75. The consensus price target is $64.00.
Enbridge Inc. (NYSE: ENB) was downgraded to Sector Perform from Outperform at Scotiabank and to In-Line from Outperform at Evercore ISI. Shares closed up 0.7% at $37.25 on Friday but were indicated down 4% at $35.75 on Monday on news that its line-3 replacement project has been delayed.
Extended Stay America Inc. (NASDAQ: STAY) was raised to Buy from Neutral at Goldman Sachs. The shares closed at $18.60, in a 52-week range of $14.77 to $22.58 and with a consensus price target of $21.32.
Foot Locker Inc. (NYSE: FL) was raised to Buy from Hold and the price target was raised to $73 from $64 (versus a $63.07 close) at Pivotal Research.
Group 1 Automotive Inc. (NYSE: GPI) was raised to Buy from Neutral with a $77 target price (versus a $62.11 close) at Goldman Sachs.
Guidewire Software Inc. (NYSE: GWRE) was downgraded to Neutral from Overweight and the price target was lowered to $90 from $95 (versus a $93.62 close) at Piper Jaffray.
Hasbro Inc. (NASDAQ: HAS) was raised to Market Perform from Underperform and the price target was raised to $88 from $75 (versus an $88.02 close) at BMO Capital Markets.
Immunogen Inc. (NASDAQ: IMGN) was down 46% at $2.51 on Friday, and H.C. Wainwright downgraded it to Neutral from Buy. The 52-week range is $2.27 to $13.41.
Sponsored: Find a Qualified Financial Advisor
Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to 3 fiduciary financial advisors in your area in 5 minutes. Each advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you’re ready to be matched with local advisors that can help you achieve your financial goals, get started now.